These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1788827)

  • 21. Thrombin inhibition compared with other antithrombotic drugs in rats.
    Schumacher WA; Heran CH; Steinbacher TE; Megill JR; Bird JE; Giancarli MR; Durham SK
    Thromb Res; 1992 Oct; 68(2):157-66. PubMed ID: 1475778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of thrombin inhibitors on tissue plasminogen activator induced thrombolysis in a rat model.
    Klement P; Borm A; Hirsh J; Maraganore J; Wilson G; Weitz J
    Thromb Haemost; 1992 Jul; 68(1):64-8. PubMed ID: 1514174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin adheres to the damaged arterial wall and inhibits its thrombogenicity.
    Araki H; Muramoto J; Nishi K; Jougasaki M; Inoue M
    Circ Res; 1992 Sep; 71(3):577-84. PubMed ID: 1499106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.
    Hennan JK; Hong TT; Shergill AK; Driscoll EM; Cardin AD; Lucchesi BR
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1151-6. PubMed ID: 12023550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin.
    Krpski WC; Bass A; Kelly AB; Marzec UM; Hanson SR; Harker LA
    Circulation; 1990 Aug; 82(2):570-7. PubMed ID: 2372903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels.
    Yamashita T; Yamamoto J; Sasaki Y; Matsuoka A
    Thromb Res; 1993 Jan; 69(1):93-100. PubMed ID: 8465278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN; Girard D; Lochot S; Lecoffre C
    Br J Pharmacol; 1994 Dec; 113(4):1209-14. PubMed ID: 7889274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model.
    Thiagarajan P; Benedict CR
    Circulation; 1997 Oct; 96(7):2339-47. PubMed ID: 9337209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective Prevention of Arterial Thrombosis with Albumin-Thrombin Inhibitor Conjugates.
    Marcos-Contreras OA; Myerson JW; Nong J; Brenner JS; Muzykantov VR; Glassman PM
    Mol Pharm; 2023 Nov; 20(11):5476-5485. PubMed ID: 37823223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alcohol withdrawal on responses of platelets from alcoholics--a study using platelet-rich plasma from blood anticoagulated with D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone (FPRCH2Cl).
    Rand ML; Neiman J; Jakowec DM; Packham MA
    Thromb Haemost; 1990 Apr; 63(2):178-82. PubMed ID: 2363118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antithrombotic drugs in a rat model of aspirin-insensitive arterial thrombosis.
    Schumacher WA; Steinbacher TE; Heran CL; Megill JR; Durham SK
    Thromb Haemost; 1993 May; 69(5):509-14. PubMed ID: 8322273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A non-occlusive model of arterial thrombus formation in the rat and its modification by inhibitors of platelet function, or thrombin activity.
    Butler KD; Ambler J; Dolan S; Giddings J; Talbot MD; Wallis RB
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):155-65. PubMed ID: 1606287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs.
    Couture L; Richer LP; Mercier M; Hélie C; Lehoux D; Hossain SM
    J Pharmacol Toxicol Methods; 2013; 67(2):91-7. PubMed ID: 23231926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
    Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCH-2763, a novel potent parenteral thrombin inhibitor, is an effective antithrombotic agent in rodent models of arterial and venous thrombosis--comparisons with heparin, r-hirudin, hirulog, inogatran and argatroban.
    Finkle CD; St Pierre A; Leblond L; Deschenes I; DiMaio J; Winocour PD
    Thromb Haemost; 1998 Feb; 79(2):431-8. PubMed ID: 9493603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulant and antithrombotic action of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
    Kaiser B; Richter M; Hauptmann J; Markwardt F
    Pharmazie; 1991 Feb; 46(2):128-31. PubMed ID: 1852761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local delivery of an antithrombin inhibits platelet-dependent thrombosis.
    Scott NA; Nunes GL; King SB; Harker LA; Hanson SR
    Circulation; 1994 Oct; 90(4):1951-5. PubMed ID: 7923684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor.
    Heras M; Chesebro JH; Penny WJ; Bailey KR; Badimon L; Fuster V
    Circulation; 1989 Mar; 79(3):657-65. PubMed ID: 2521818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.